Bringing the fundamentals into focus…
Back to Ionis Pharmaceuticals, Inc.
How Ionis Pharmaceuticals, Inc. stacks up
IONS · against 203 other Healthcare companies of similar size
Overall
19/ 100
Near the bottom of its peers.
Ranked #202 of 204 · scores higher than 1% of peers
Bars: peers in each 10-point band of the overall score3 peers with an overall score of 10–19, including IONS · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around IONS| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 3 | 921.9B INR (≈$11.1B) | 82 | 84 | 80 | 94 | 0 / 2 | |
| 4 | 936.1B JPY (≈$6.4B) | 80 | 65 | 86 | 94 | 0 / 2 | |
| 5 | 40.3B SEK (≈$4.0B) | 79 | 43 | 84 | 97 | 0 / 2 | |
| 198 | 31.0B CNY (≈$4.3B) | 26 | 0 | 4 | 29 | 0 / 2 | |
| 198 | 8.7B USD | 26 | 8 | 78 | 2 | 2 / 2 | |
| 200 | 3.7B USD | 24 | 8 | 9 | 1 | 0 / 2 | |
| 200 | 5.4B USD | 24 | 8 | — | 8 | 1 / 2 | |
| 202 | 6.7B USD | 19 | 8 | 30 | 20 | 2 / 2 | |
| 203 | 3.4B USD | 17 | 8 | — | 20 | 2 / 2 | |
| 204 | 34.9B CNY (≈$4.9B) | 16 | 0 | 0 | 22 | 1 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score